Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CAD | P27708 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 2/20 | 0.31 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.31 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.31 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.30 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514998 | 1.00 | GAA (0.48) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL25401240 | 1.00 | GAA (0.48) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL7720643 | 0.88 | LMNA (0.46) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL29766719 | 0.88 | LMNA (0.46) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL6561125 | 0.85 | GAA (0.45) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL6561121 | 0.85 | GAA (0.45) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL7752351 | 0.85 | GAA (0.47) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL6323493 | 0.83 | GAA (0.46) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL78947 | 0.83 | LMNA (0.48) | GAALMNATSHRPOLBSMN1; SMN2 | |
| SCHEMBL21628058 | 0.83 | GAA (0.49) | GAALMNATSHRPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3693357-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDONE CARBOXYLIC ACID OR ALKALI METAL SALT THEREOF | AJINOMOTO KK (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-110891934-B | Process for producing optically active pyrrolidone carboxylic acid or alkali metal salt thereof | 味之素株式会社 | 2023-12-12 | — | — | CN | disclosed |
| EP-3693357-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDONE CARBOXYLIC ACID OR ALKALI METAL SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2020-08-12 | — | — | EP | disclosed |
| CN-110891934-A | Process for producing optically active pyrrolidone carboxylic acid or alkali metal salt thereof | 味之素株式会社 | 2020-03-17 | — | — | CN | disclosed |
| US-20020072601-A1 | Method for forming amino acid derivatives from tricyclic diketopiperazines | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020072601-A1 | Method for forming amino acid derivatives from tricyclic diketopiperazines | AADAT, GLUL, ASNS | GAA 2288/4885LMNA 1763/4885TSHR 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.